143 related articles for article (PubMed ID: 37355392)
1. Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center.
Schuring N; Stam WT; Plat VD; Kalff MC; Hulshof MCCM; van Laarhoven HWM; Derks S; van der Peet DL; van Berge Henegouwen MI; Daams F; Gisbertz SS
Eur J Surg Oncol; 2023 Oct; 49(10):106947. PubMed ID: 37355392
[TBL] [Abstract][Full Text] [Related]
2. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
3. Impact of radial margins after esophagectomy for esophageal cancer.
Bravo-Iñiguez CE; He Z; Dezube AR; Mazzola E; Yelamanchili N; Zhao L; Bueno R; Swanson SJ; White A; Wiener DC; Jaklitsch MT; Wee JO
Eur J Surg Oncol; 2021 Sep; 47(9):2313-2322. PubMed ID: 33714649
[TBL] [Abstract][Full Text] [Related]
4. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
5. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
[TBL] [Abstract][Full Text] [Related]
6. The effect of anastomotic leakage on the incidence of recurrence after tri-modality therapy for esophageal adenocarcinomas.
Stam WT; Schuring N; Hulshof M; van Laarhoven H; Derks S; van Berge Henegouwen MI; van der Peet DL; Gisbertz SS; Daams F
J Surg Oncol; 2023 Aug; 128(2):218-230. PubMed ID: 37133757
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent.
Parry K; Visser E; van Rossum PS; Mohammad NH; Ruurda JP; van Hillegersberg R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1292-300. PubMed ID: 26334295
[TBL] [Abstract][Full Text] [Related]
8. Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in Japan.
Jingu K; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Kishida K; Omata S; Sato Y; Kadoya N
Esophagus; 2022 Oct; 19(4):639-644. PubMed ID: 35575821
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies in recurrent esophageal or junctional cancer.
Butter R; Lagarde SM; van Oijen MGH; Anderegg MCJ; Gisbertz SS; Meijer SL; Hulshof MCCM; Bergman JJGHM; van Berge Henegouwen MI; van Laarhoven HWM
Dis Esophagus; 2017 Sep; 30(9):1-9. PubMed ID: 28859371
[TBL] [Abstract][Full Text] [Related]
10. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
[TBL] [Abstract][Full Text] [Related]
11. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
[TBL] [Abstract][Full Text] [Related]
12. CROSS and beyond: a clinical perspective on the results of the randomized ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study.
van der Woude SO; Hulshof MC; van Laarhoven HW
Chin Clin Oncol; 2016 Feb; 5(1):13. PubMed ID: 26932437
[TBL] [Abstract][Full Text] [Related]
13. Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
Tsai PC; Chien HC; Hsu PK; Hung JJ; Huang CS; Hsu WH; Hsu HS
BMC Cancer; 2022 Jun; 22(1):637. PubMed ID: 35681112
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion and extracapsular invasion are risk factors for distant recurrence after preoperative chemoradiotherapy and oesophagectomy in patients with oesophageal squamous cell carcinoma.
Hsu PK; Chien LI; Wang LC; Chou TY;
Eur J Cardiothorac Surg; 2017 Jun; 51(6):1188-1194. PubMed ID: 28329246
[TBL] [Abstract][Full Text] [Related]
15. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
16. Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy.
Boerner T; Carr RA; Hsu M; Michel A; Tan KS; Vos E; Sihag S; Bains MS; Ku GY; Wu AJ; Jones DR; Molena D
Int J Cancer; 2023 May; 152(10):2109-2122. PubMed ID: 36573352
[TBL] [Abstract][Full Text] [Related]
17. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
18. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).
Ruhstaller T; Thuss-Patience P; Hayoz S; Schacher S; Knorrenschild JR; Schnider A; Plasswilm L; Budach W; Eisterer W; Hawle H; Mariette C; Hess V; Mingrone W; Montemurro M; Girschikofsky M; Schmidt SC; Bitzer M; Bedenne L; Brauchli P; Stahl M; ; ; ;
Ann Oncol; 2018 Jun; 29(6):1386-1393. PubMed ID: 29635438
[TBL] [Abstract][Full Text] [Related]
20. Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer.
Sugase T; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Fujii Y; Mukai Y; Mikamori M; Hasegawa S; Haraguchi N; Akita H; Nishimura J; Wada H; Matsuda C; Yasui M; Miyata H
Oncology; 2022; 100(12):655-665. PubMed ID: 36198297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
